Updated:
PharmaLogic Holdings Corp.
PharmaLogic Holdings Corp. is a family office that built a radiopharmaceutical CDMO platform, advancing patient access to novel radiopharmaceuticals.
PharmaLogic Holdings Corp.
PharmaLogic Holdings Corp. is a family office that owns and operates PharmaLogic, a radiopharmaceutical contract development and manufacturing organization (CDMO). Its primary asset is a network of radiopharmacies and manufacturing facilities that serve pharmaceutical sponsors advancing novel radiopharmaceuticals. Wealth origin for the underlying family has not been publicly disclosed. The firm's strategy centers on providing CDMO services for both diagnostic and therapeutic radiopharmaceuticals, spanning clinical development through commercial launch. Its offerings include CMO services for diagnostics and therapeutics, as well as supply-chain and radiopharmacy operations. Recent deals include a June 2025 acquisition of a majority stake in Agilera Pharma AS (per the firm, June 2025). PharmaLogic also supported Ratio Therapeutics' Phase 1/2 study of a FAP-targeted radiopharmaceutical, supplying the first cohort dosing announced in December 2025 (per the firm, December 2025). Geographic operations are primarily in North America, with a new PET radiopharmaceutical manufacturing facility opened in Atlanta, Georgia in April 2026. PharmaLogic operates from a single headquarters in Boca Raton. The firm announced the opening of its new Atlanta facility in April 2026, expanding its domestic manufacturing footprint. No additional offices, team size, or philanthropic vehicles have been publicly identified. A structural differentiator is PharmaLogic's focus on radiopharmaceuticals as a niche within the CDMO space, an area with high regulatory and technical barriers. The family office structure allows long-term capital commitment to building out specialized infrastructure, distinct from private equity-backed CDMOs that may rotate assets on a shorter horizon.
General information
Firm type
Single Family Office
Year founded
—
AUM
Undisclosed
Location
Region
North America
Country
United States
City
Boca Raton
Corporate office
Boca Raton, FL, United States
Sector focus
Frequently asked questions
Who runs investment decisions at PharmaLogic Holdings Corp.?
PharmaLogic Holdings Corp. has not publicly disclosed its principal operators or investment decision-makers. The firm's public-facing entity, PharmaLogic, lists a leadership team on its website but no named family-office principals have been identified.
How does PharmaLogic source proprietary deal flow?
PharmaLogic sources deal flow through a combination of pharmaceutical partnerships and acquisitions. The firm identifies and acquires radiopharmaceutical manufacturing assets, such as its June 2025 majority stake in Agilera Pharma AS (per the firm, June 2025). It also partners with drug developers like Ratio Therapeutics for clinical supply agreements.
Is PharmaLogic structured as a single family office or does it operate more like a venture firm?
PharmaLogic Holdings Corp. is structured as a single family office that owns and operates an operating company, PharmaLogic, rather than functioning as a venture firm. The family office's single known investment is the radiopharmaceutical CDMO platform, making it more akin to a holding company than a diversified investment vehicle.
Does PharmaLogic participate in fund commitments or only direct deals?
PharmaLogic has not been observed committing to external funds. Its disclosed activities are all direct investments in its own operating platform through acquisitions and facility builds, such as the Atlanta manufacturing facility opened in April 2026 (per the firm, April 2026).
What investment stages does PharmaLogic typically target?
PharmaLogic targets the clinical-to-commercial stage within radiopharmaceutical development. Its CDMO services span from clinical development support through commercial launch, as noted on the firm's website. The firm does not publicly disclose any early-stage venture investments outside its own platform.
Where does the underlying wealth come from?
The wealth origin for the family behind PharmaLogic Holdings Corp. has not been publicly disclosed. No information about the founding family or the source of capital is available in public sources.
Does PharmaLogic maintain philanthropic structures, and how are they separated?
PharmaLogic Holdings Corp. has not publicly disclosed any philanthropic foundations or structures. No separate charitable entity associated with the family office has been identified.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: